moelsoud.bsky.social
@moelsoud.bsky.social
The FDA has approved the weight-loss drug Zepbound for treating obstructive sleep apnea (OSA) in patients with obesity. Developed by Eli Lilly, the drug is part of the GLP-1 receptor agonists class and requires a low-calorie diet and increased physical activity as part of the treatment plan.
December 21, 2024 at 8:32 PM
Reposted
US hospital operator Ascension notifies ~5.6M patients and staffers that their personal and health data was stolen in a May 2024 cyberattack (Sergiu Gatlan/BleepingComputer)

Main Link | Techmeme Permalink
December 20, 2024 at 4:21 PM
Reposted
Feds clear the way for robotaxis without steering wheel and pedals
Feds clear the way for robotaxis without steering wheel and pedals
The National Highway Traffic Safety Administration on Friday proposed a new national framework that could make it easier for companies to deploy at scale autonomous vehicles without traditional manual driving controls – like steering wheels, pedals, and…
tcrn.ch
December 20, 2024 at 8:20 PM